Embrex Sues Breuil, New Tech Solutions Over "In Ovo" Injection Device

Law360, New York (December 15, 2003, 12:00 AM EST) -- Agricultural biotech company Embrex sued rivals Breuil S.A. of Landivisiau, France and New Tech Solutions, Inc. of Gainesville, GA in the U.S. District Court of Eastern North Carolina, alleging that an their "in ovo" injection device infgringes two of its patents.

Embrex is seeking injunctive relief and monetary damages for the alleged infringements and is demanding a jury trial.

The patents in question are U.S. Patent Nos. 5,745,228 ('228) and 5,900,929 ('929), according to Embrex.

Embrex's Patent No. '228 relates to the company's proprietary method for...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.